Real-time enrollment status for this leukemia, lymphocytic, chronic, b-cell clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 11:15 AM UTC
| NCT Number | NCT06364423 |
| Recruiting Status | Recruiting |
| Condition | Leukemia, Lymphocytic, Chronic, B-Cell |
| Phase | PHASE1 |
| Target Enrollment | 132 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 16, 2026 (4 days ago) |
As of July 20, 2026: Clinical trial NCT06364423 is currently recruiting participants. This phase1 study for leukemia, lymphocytic, chronic, b-cell is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06364423 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06364423 was last updated 4 days ago (July 16, 2026). HelloStudys verifies this status automatically.